TherapeuticsMD, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | 754.3% | 754.3% | -897.6% |
| FY2012 | 2,450.6% | 2,450.6% | -592.7% |
| FY2013 | -52.0% | -52.0% | -45.8% |
| FY2014 | -112.0% | -112.0% | -91.8% |
| FY2015 | -134.9% | -134.9% | -115.4% |
| FY2016 | -70.5% | -70.5% | -63.1% |
| FY2017 | -59.2% | -59.2% | -53.7% |
| FY2018 | -136.0% | -77.6% | -62.6% |
| FY2019 | -1,914.4% | -86.4% | -66.2% |
| FY2020 | 148.0% | -161.4% | -101.1% |
| FY2021 | 184.2% | 184.2% | -101.7% |
| FY2022 | 318.7% | 318.7% | 123.8% |
| FY2023 | -35.1% | -35.1% | -23.7% |
| FY2024 | -8.0% | -8.0% | -5.6% |
| FY2025 | -2.1% | -2.1% | -1.5% |